Skip to main content

IRYCIS and Mikrobiomik sign an agreement for investigations related to the human microbiota.


Last December 2022, Mikrobiomik signed a framework collaboration agreement with the Ramón y Cajal Institute for Health Research -IRYCIS-, with the aim of joining forces in the investigation and co-development of therapeutic innovations related to the human microbiota.

The objective of this collaboration is to bring to the clinic disruptive research projects that, in the future, may provide innovative therapeutic solutions for patients with diseases without an effective therapeutic alternative.

More information:


Leave a Reply